Navigation Links
Forte Research Systems Unveils the Allegro™ Research on Demand Cloud-Based Product Line
Date:11/18/2010

MADISON, Wis., Nov. 18, 2010 /PRNewswire/ -- Forte Research Systems, makers of OnCore® , the most widely adopted clinical research platform among academic research organizations and cancer centers in the United States, unveiled a new product line today, the Allegro™ Research on Demand, cloud-based clinical research management solution. The first product in the new line is Allegro CTMS@Site™, the clinical trials management system built exclusively for investigational sites.

(Photo: http://photos.prnewswire.com/prnh/20101118/CG04162)

(Photo: http://www.newscom.com/cgi-bin/prnh/20101118/CG04162)

(Logo: http://photos.prnewswire.com/prnh/20101115/CG02078LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20101115/CG02078LOGO)

Research coming out of Tufts Center for the Study Drug Development shows that over half of the clinical research being conducted worldwide is taking place in physician practices, community hospitals, and dedicated research sites. These relatively small sites are experiencing trends in the industry in ways that are distinct from large research organizations.

"Trends in the industry are creating a significant increase in administrative overhead and regulatory exposure for the sites," said Srini Kalluri, founder, president & CEO of Forte Research Systems. "We built Allegro CTMS@Site to address these specific challenges from the sites' perspective."

Pharmaceutical companies conducting clinical trials on new drugs are spreading the work among more sites as a way to increase the probability of success and to reach more potential patient participants. In turn, this trend has led individual sites to take on more trials. At the same time, while sites are grappling with more trials, the trials are becoming much more complex with a proliferation of procedures and subject eligibility criteria.

In an attempt to be more competitive and efficient in this environment, today's sites are implementing tighter financial management, overseeing regulatory compliance more intensively, striving to achieve status as a preferred partner, and adopting clinical trials management systems (CTMS) to streamline operations and replace paper-based processes.

"When it comes to CTMS, current solutions in the marketplace leave a lot to be desired," said Kalluri.

With what is currently available, sites have to choose between products with bloated functionality and complex interfaces that require up-front investments in infrastructure, have ongoing maintenance and administrative overhead, and have long training cycles with slow user adoption rates.

By contrast, the Allegro product line is built for clinical research operations excellence with no software to install and no systems administration required, real-time visibility into the entire clinical research portfolio, and a user-centric, intuitive interface that is easy to use, virtually eliminating the need for training. With Allegro CTMS@Site, sites can get up and running in a single day.

Founded in 2000 and headquartered in Madison, Wisconsin, Forte Research Systems, Inc. develops clinical and translational research management software. The company's flagship product, the OnCore® system, is the nation's most widely adopted clinical research platform among academic research organizations and cancer centers.

PercipEnz Technologies is now Forte Research Systems. Same company, new name.


'/>"/>
SOURCE Forte Research Systems
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New FORTEO® and EVISTA® Data to be Presented at Premiere Scientific Meeting for Bone and Mineral Research
2. ForteBio Announces Launch of Protein G Biosensor for Use on Companys Octet® Instruments
3. Endo Pharmaceuticals Completes Next Step in Regulatory Process for FORTESTA™ for Men With Low Testosterone
4. ForteBio Launches New Dip and Read(TM) Residual Protein A Detection Kit; Introduces Sidekick(TM) Offline Biosensor Immobilization Station for All Octet(R) Instruments
5. FORTEO(R) Increased Spine Bone Mineral Density in Patients with Glucocorticoid-Induced Osteoporosis
6. Neuro Kinetics Receives HHS Therapeutic Discovery Grant to Further Research Into Early Diagnosis of Sports Concussions
7. Access Pharmaceuticals ProLindac™ and CobaCyte™ Oncology Research Displayed at the Innovations in Cancer Prevention and Research Conference, November 17-19, 2010
8. MedImmune Announces Winners of the 5th Annual Respiratory, Inflammation and Autoimmunity Research Abstract Competition
9. CVS Caremark Research Finds Correlation Between Amount of Patient Co-pay and Prescription Abandonment
10. Pfizer Launches Global Centers for Therapeutic Innovation, a Network of Research Partnerships, With University of California, San Francisco
11. New Peripheral Vascular Device Market Research Data Covering Multiple Geographies Released by Millennium Research Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)...  In response to the opioid epidemic in ... working with Pfizer to make up to 1 million ... community health centers, free and charitable clinics, public health ... "Pfizer has a long-standing commitment to improving health outcomes ... through educational activities," said Caroline Roan , vice ...
(Date:5/23/2017)... Calif. , May 23, 2017  Leaf ... most innovative medical devices for pressure ulcer prevention, ... the American Association of Critical Care Nurses, National ... May 22-25. The Leaf Patient Monitoring ... specifically for the hospital environment.  The system seamlessly ...
(Date:5/22/2017)... , May 22, 2017  As the ... a whole continue to make the revolutionary shift ... increasingly important for ensuring positive patient outcomes and ... stakeholders are shifting focus away from clinical trials ... effects of long-term specialty drug therapy utilization in ...
Breaking Medicine Technology:
(Date:6/24/2017)... Fla. (PRWEB) , ... June 24, 2017 , ... ... is now offering genetic testing for medications in select Florida and Texas doctors' ... pharmacogenomics. , This new application of genetic testing recognizes the role genes ...
(Date:6/24/2017)... , ... June 24, 2017 , ... The weather is ... time outdoors. Home and business owners should be aware that the summer months provide ... In fact, mechanical locks and keys can be negatively affected from direct exposure to ...
(Date:6/23/2017)... ... June 23, 2017 , ... ... and will ultimately do significant harm to people with all chronic conditions, including ... "While it leaves in place the Affordable Care Act (ACA) requirement that insurers ...
(Date:6/23/2017)... ... June 24, 2017 , ... Studies show evidence that carotenoids and ... of visual loss in these patients. , But how often do ophthalmologists and optometrists ... to patients at risk of or with early symptoms of AMD? A study ...
(Date:6/23/2017)... ... 2017 , ... Military Connection friend and veteran advocate Micaela Bensko ... Atlantic lounge. , Bensko is no stranger to the plight of the disabled. ... life to supporting our wounded veterans. A world-class photographer, her riveting photos “The Wounds ...
Breaking Medicine News(10 mins):